SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $90,802,681 | +33.9% | 90,815,000 | +31.6% | 5.68% | +164.7% |
Q4 2022 | $67,802,325 | +1.3% | 69,010,000 | 0.0% | 2.14% | +32.9% |
Q3 2022 | $66,940,000 | -0.1% | 69,010,000 | 0.0% | 1.61% | +4.9% |
Q2 2022 | $66,983,000 | -1.0% | 69,010,000 | 0.0% | 1.54% | 0.0% |
Q1 2022 | $67,673,000 | -0.5% | 69,010,000 | 0.0% | 1.54% | -13.6% |
Q4 2021 | $68,018,000 | +0.3% | 69,010,000 | 0.0% | 1.78% | -9.7% |
Q3 2021 | $67,802,000 | +17.5% | 69,010,000 | +17.5% | 1.97% | +9.2% |
Q2 2021 | $57,717,000 | +1.7% | 58,708,000 | -0.3% | 1.81% | -20.2% |
Q1 2021 | $56,759,000 | +1.7% | 58,877,000 | 0.0% | 2.26% | -35.2% |
Q4 2020 | $55,835,000 | +46.9% | 58,877,000 | +42.7% | 3.50% | +1.7% |
Q3 2020 | $38,009,000 | +44.8% | 41,266,000 | +38.3% | 3.44% | -4.5% |
Q2 2020 | $26,252,000 | +156.4% | 29,830,000 | +134.0% | 3.60% | +87.2% |
Q1 2020 | $10,237,000 | – | 12,749,000 | – | 1.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |